Skip to content

Clinical Investigation to Assess the Clinical Performance of the LumbaCure® Intervention on Chronic Low Back Pain Patients.

Randomized Clinical Investigation to Assess Preliminary Clinical Performance, Effectiveness and Safety of the LumbaCure® (prototype C190070.01) Medical Device When Used in Patients Suffering from Chronic Low Back Pain

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06138002
Enrollment
22
Registered
2023-11-18
Start date
2023-10-02
Completion date
2024-09-12
Last updated
2024-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Brief summary

Low Back Pain (LBP) is one of the common causes of morbidity worldwide, with a one-month prevalence of 23.3 %. Number of people with LBP reached 577 million people in 2020. LBP has been the leading cause of years lived with disability from 1990 to 2017. The highest incidence of LBP is in people in their third decade of age. LBP is a complex disease difficult to treat as most of these cases (80 - 90 %) are classified as non-specific meaning that the pain cannot be attributed to any specific injury or pathology. Until now exercise therapy is commonly used as the treatment of choice in the revalidation program of LBP. The aim of physical treatment is to improve function and prevent disability from getting worse. LumbaCure® is a robotic system driven by a proprietary movement algorithm to induce a specific and controlled mobilization of the hips and the low back in patient requiring treatment by physical exercises due to orthopedic disorder, especially low back pain. The investigation include an intervention period of 4 weeks The main objective is to compare the impact on disability (Oswestry disability Index) and movement performance of the interventions (LumbaCure® vs physical exercises supervised by the physiotherapist) in two parallel groups of patients suffering from chronic low back pain. The investigation includes an intervention period of 4 weeks and a follow-up period of 6 months (post intervention period).

Interventions

LumbaCure®is a robotic system that systematically moves the spine of affected patients with a complex proprietary algorithm.

PROCEDUREPhysical Exercises supervised by the physiotherapist

A set of core stability/active qualitative mobilization exercises have been defined, corresponding to standard exercises proposed in center rehabilitation program

Sponsors

Odix
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic non-specific LBP (without red flag) * Patient did not increase, on a long-term basis, his/her regular physical activity in the past 2 months. * LBP is the principal musculoskeletal condition * Aged between 18 and 65 years old * Able to read and understand questionnaires and communicate with the physiotherapist. * Average Back Pain intensity over the last week above 2, assessed on Numerical Pain Rating Scale from 0 to 10 anchored with no pain at 0 and worst pain imaginable at 10. * ODI score \> 20

Exclusion criteria

* Suspected or confirmed serious pathology (i.e infection, fracture, cancer, inflammatory arthritis, ….) * Radicular pain * Radiculopathy * Cognitive impairment that precludes participant from consenting, completing investigation questionnaires or complying with recommendations * Previous spine surgery in the last 3 months * Pregnant women * body weight \> 120 kg * Neurological disease * Fibromyalgia

Design outcomes

Primary

MeasureTime frameDescription
DisabilityBaseline, week 4 (end of intervention period)The change of the Oswestry Disability Index (ODI) between baseline and the end of the intervention period (4 weeks)

Secondary

MeasureTime frameDescription
Patient global satisfaction of the therapyEnd of intervention period (week 4)A single score of satisfaction will be calculated based on a set of two questions: \> How satisfied or dissatisfied are you with the ability of the LumbaCure® / Physical exercises intervention to improve your low back pain condition (7-points scale; 1 = completely dissatisfied; 7 = completely satisfied)? How globally would you rate your experience, on the LumbaCure® device/with physical exercises (7-point Likert scale (1 = very bad; 7 = excellent)) ?
Function responding rateweek 4 (intervention period) and at month 1, month 3 and month 6 (follow-up period)Number and percentage of patients presenting an improvement of at least 1.5 points from baseline in the pain specific function scale
Kinesiophobiaweek 4Change in fear of movements and attitudes and behavior from baseline towards pain score, evaluated through the Tampa questionnaire.
Kinesiophobia responding rateweek 4 (intervention period) and month 1, month 3 and month 6 (follow-up period)Number and percentage of patients presenting an improvement of at least 6 points from baseline in Tampa scale.
Anxiety and depressionweek 4Change in Anxiety and depression score from baseline, assessed by the HAD questionnaire
Anxiety and depression responding rateweek 4 (intervention period) and month 1, month 3 and month 6 (follow-up period)Number and percentage of patients presenting an improvement of at least 2 points from baseline for each sub-scale anxiety and depression in the two treatment arms
Physiotherapist global satisfactionweek 4A single score of satisfaction reported by the physiotherapist: * How satisfied or dissatisfied are you with the ability of the LumbaCure® intervention to improve your patient low back pain condition (7-points scale; 1 = completely dissatisfied; 7 = completely satisfied); ? * How satisfied or dissatisfied are you with the ability of the Physical exercises intervention to improve your patient low back pain condition (7-points scale; 1 = completely dissatisfied; 7 = completely satisfied)?
Disabilityweek2 (intervention period); month 1, month 3 and month 6 follow-up periodThe change in the ODI score between baseline and follow-up period
Disability responding rateweek 2, week 4 (intervention period) and at month 1, month 3 and month 6 follow-up periodNumber and percentage of patients presenting an improvement from baseline of at least 10 points in the ODI
Back Painweek 1, week 2, week 3 and week 4 (the intervention period)Changes in the average back pain intensity over the last week from baseline, assessed on Numerical Pain Rating Scale from 0 to 10 (0 for no pain and 10 for worst pain imaginable)
Back Pain responding rateweek 2, week 4 (intervention period) and at month 1, month 3 and month 6 (follow-up period)Number and percentage of patients presenting an improvement from baseline of at least 1.5 points in the Numerical Pain rating scale
Functionweek 4Change in function score from baseline, assessed using the Pain Specific Functional Scale. The PSFS requires participants to identify three problematic activities and to rate these activities on a scale from 0 to 10.

Other

MeasureTime frameDescription
Measurement in Dynamic/static situationBaseline and week 4 (end of intervention period)During standardized everyday dynamic/static movements (5x) : sit-to-stand, 5 repetitions; climbing stairs, 5 repetitions; and bending task, 30 sec position maintenance: \- Patient muscular activation of the back muscles is measured by surface EMG (sEMG). Targeted muscles: Iliocostalis, longissimus, multifidus, obliques.
Flexion/extension amplitudesBaseline and week 4 (end of intervention period)Flexion/extension amplitudes measured using the Tergumed or DavidBack device.
ForceBaseline and week 4 (end of intervention period)Force measured using the Tergumed or DavidBack device.
Distance finger to floorBaseline and week 4 (end of intervention period)The ability of the patient to flex the lower back via fingertips to floor distance.
Adverse eventsbaseline, week 1, week 2, week 3, week 4The occurrence, intensity and severity of adverse events will be monitored on both arm
Patient mobilizationLumbaCure® session 1 and session 12 : Week 1 (Day 0) and Week 4 (Day 25)o Pressure distribution using a pressure mat

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026